Since activated CD8+ T cells can produce IFN-γ, which is reported to induce PD-L1 expression in surrounding tumor and inflammatory cells [6], the higher PD-L1 expression after BCG might be at least in part explained by the accelerated infiltration of CD8+ T cells in the BCG-treated patients. The gene discussed is CD274; the disease is neoplasm.